📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Managing type 2 diabetes: targeting a microbial enzyme as a novel treatment option. (2023)

First Author: Keller-Pintér A

Attributed to: BBSRC Institute Strategic Programme: Food Microbiome and Health (FMH) Partner grant funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41392-023-01694-z

PubMed Identifier: 38057293

Publication URI: http://europepmc.org/abstract/MED/38057293

Type: Journal Article/Review

Volume: 8

Parent Publication: Signal transduction and targeted therapy

Issue: 1

ISSN: 2059-3635